carmustine has been researched along with Mediastinal Neoplasms in 9 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Mediastinal Neoplasms: Tumors or cancer of the MEDIASTINUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "46 patients with Hodgkin's disease received Dexa-BEAM chemotherapy followed by radiotherapy." | 1.31 | [The 1st results of the combined therapy of recurrent and refractory forms of lymphogranulomatosis (polychemotherapy, radiation therapy and the removal of the residual mediastinal formation)]. ( Dzhumabaeva, BT; Efimov, IV; Kaplanskaia, IB; Margolin, OV; Moiseeva, TN; Pivnik, AV; Rasstrigin, NA; Roshchina, LS; Shavlokhov, VS; Sotnikov, VM; Stroiakovskiĭ, DL, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eroglu, C | 1 |
| Kaynar, L | 1 |
| Orhan, O | 1 |
| Keklik, M | 1 |
| Sahin, C | 1 |
| Yildiz, OG | 1 |
| Mentes, S | 1 |
| Kurnaz, F | 1 |
| Aslan, D | 1 |
| Sivgin, S | 1 |
| Soyuer, S | 1 |
| Eser, B | 1 |
| Cetin, M | 1 |
| Unal, A | 1 |
| Papageorgiou, SG | 1 |
| Diamantopoulos, P | 1 |
| Levidou, G | 1 |
| Angelopoulou, MK | 1 |
| Economopoulou, P | 1 |
| Efthimiou, A | 1 |
| Constantinou, N | 1 |
| Katsigiannis, A | 1 |
| Korkolopoulou, P | 1 |
| Pappa, V | 1 |
| Economopoulou, C | 1 |
| Georgiou, G | 1 |
| Dimou, M | 1 |
| Tsirigotis, P | 1 |
| Kyrtsonis, MC | 1 |
| Kotsianidis, I | 1 |
| Kalpadakis, C | 1 |
| Dimopoulos, MA | 1 |
| Beris, P | 1 |
| Meletis, J | 1 |
| Pangalis, GA | 1 |
| Dervenoulas, J | 1 |
| Panayiotidis, P | 1 |
| Vassilakopoulos, TP | 1 |
| Meyer, F | 1 |
| Buerger, T | 1 |
| Gebauer, T | 1 |
| Halloul, Z | 1 |
| Popat, U | 1 |
| Przepiork, D | 1 |
| Champlin, R | 1 |
| Pugh, W | 1 |
| Amin, K | 1 |
| Mehra, R | 1 |
| Rodriguez, J | 1 |
| Giralt, S | 1 |
| Romaguera, J | 1 |
| Rodriguez, A | 1 |
| Preti, A | 1 |
| Andersson, B | 1 |
| Khouri, I | 1 |
| Claxton, D | 1 |
| de Lima, M | 1 |
| Donato, M | 1 |
| Anderlini, P | 1 |
| Gajewski, J | 1 |
| Cabanillas, F | 1 |
| van Besien, K | 1 |
| Stroiakovskiĭ, DL | 1 |
| Pivnik, AV | 1 |
| Shavlokhov, VS | 1 |
| Sotnikov, VM | 1 |
| Moiseeva, TN | 1 |
| Rasstrigin, NA | 1 |
| Margolin, OV | 1 |
| Efimov, IV | 1 |
| Dzhumabaeva, BT | 1 |
| Kaplanskaia, IB | 1 |
| Roshchina, LS | 1 |
| Weihrauch, MR | 1 |
| Re, D | 1 |
| Scheidhauer, K | 1 |
| Ansén, S | 1 |
| Dietlein, M | 1 |
| Bischoff, S | 1 |
| Bohlen, H | 1 |
| Wolf, J | 1 |
| Schicha, H | 1 |
| Diehl, V | 1 |
| Tesch, H | 1 |
| Schuler, D | 1 |
| Koós, R | 1 |
| Krauze, I | 1 |
| Péter, A | 1 |
| Ferrant, A | 1 |
| Hamoir, V | 1 |
| Binon, J | 1 |
| Michaux, JL | 1 |
| Sokal, G | 1 |
| Sullivan, MP | 1 |
| Boyett, J | 1 |
| Pullen, J | 1 |
| Crist, W | 1 |
| Doering, EJ | 1 |
| Trueworthy, R | 1 |
| Hvizdala, E | 1 |
| Ruymann, F | 1 |
| Steuber, CP | 1 |
1 trial available for carmustine and Mediastinal Neoplasms
| Article | Year |
|---|---|
Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Carmustine; Child; Child, Preschool; C | 1985 |
8 other studies available for carmustine and Mediastinal Neoplasms
| Article | Year |
|---|---|
Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Carmustin | 2015 |
Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherap | 2013 |
Unusual implantation site of a port-a-cath system via the right femoral vein.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Catheterization, Central Venous; | 2002 |
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation | 1998 |
[The 1st results of the combined therapy of recurrent and refractory forms of lymphogranulomatosis (polychemotherapy, radiation therapy and the removal of the residual mediastinal formation)].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chemotherapy, Adjuvan | 2000 |
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cy | 2001 |
Paraneoplastic syndrome in childhood.
Topics: Brain Diseases; Carmustine; Child, Preschool; Humans; Lomustine; Male; Mediastinal Neoplasms; Methot | 1977 |
Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Comb | 1985 |